Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer
Journal of Clinical Investigation · 15.03.2024 · 134 (6)
DOI: 10.1172/jci175834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 25.01.2024. Verfasst von Zepang Sun und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medi…. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.
Abstract (Originalsprache)
BACKGROUND The tumor immune microenvironment can provide prognostic and therapeutic information. We aimed to develop noninvasive imaging biomarkers from computed tomography (CT) for comprehensive evaluation of immune context and investigate their associations with prognosis and immunotherapy response in gastric cancer (GC). METHODS This study involved 2,600 patients with GC from 9 independent cohorts. We developed and validated 2 CT imaging biomarkers (lymphoid radiomics score [LRS] and myeloid radiomics score [MRS]) for evaluating the IHC-derived lymphoid and myeloid immune context respectively, and integrated them into a combined imaging biomarker [LRS/MRS: low(−) or high(+)] with 4 radiomics immune subtypes: 1 (−/−), 2 (+/−), 3 (−/+), and 4 (+/+). We further evaluated the imaging biomarkers’ predictive values on prognosis and immunotherapy response. RESULTS The developed imaging biomarkers (LRS and MRS) had a high accuracy in predicting lymphoid (AUC range: 0.765–0.773) and myeloid (AUC range: 0.736–0.750) immune context. Further, similar to the IHC-derived immune context, 2 imaging biomarkers (HR range: 0.240–0.761 for LRS; 1.301–4.012 for MRS) and the combined biomarker were independent predictors for disease-free and overall survival in the training and all validation cohorts (all P < 0.05). Additionally, patients with high LRS or low MRS may benefit more from immunotherapy ( P < 0.001). Further, a highly heterogeneous outcome on objective response rate was observed in 4 imaging subtypes: 1 (−/−) with 27.3%, 2 (+/−) with 53.3%, 3 (−/+) with 10.2%, and 4 (+/+) with 30.0% ( P < 0.0001). CONCLUSION The noninvasive imaging biomarkers could accurately evaluate the immune context and provide information regarding prognosis and immunotherapy for GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Surgery and.
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.
- College of Computer Science, Nankai University, Tianjin, China.
- Department of Gastrointestinal Surgery, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Graduate Group of Epidemiology, UCD, Davis, California, USA.
Förderung
- None
Zitieren
APA
Sun, Z., Zhang, T., Ahmad, M. U., Zhou, Z., Qiu, L., Zhou, K., Xiong, W., Xie, J., Zhang, Z., Chen, C., Yuan, Q., Chen, Y., Feng, W., Xu, Y., Yu, L., Wang, W., Yu, J., Li, G., & Jiang, Y. (2024). Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer. Journal of Clinical Investigation, 134(6). https://doi.org/10.1172/jci175834
Vancouver
Sun Z, Zhang T, Ahmad MU, Zhou Z, Qiu L, Zhou K, et al. Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer. Journal of Clinical Investigation. 2024;134(6). doi:10.1172/jci175834
BibTeX
@article{Sun2024,
author = {Sun, Zepang and Zhang, Taojun and Ahmad, M Usman and Zhou, Zixia and Qiu, Liang and Zhou, Kangneng and Xiong, Wenjun and Xie, Jingjing and Zhang, Zhicheng and Chen, Chuanli and Yuan, Qingyu and Chen, Yan and Feng, Wanying and Xu, Yikai and Yu, Lequan and Wang, Wei and Yu, Jiang and Li, Guoxin and Jiang, Yuming},
title = {Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {6},
doi = {10.1172/jci175834}
}
EUVIMED